Myanmar vs Sudan: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Myanmar
71.0%
in 2025
Sudan
74.0%
in 2025
Myanmar rank
133rd
Sudan rank
131st
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Myanmar
- Sudan
How they compare
Sudan currently reports 74.0% against 71.0% in Myanmar, a difference of 3.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Sudan ahead.
Myanmar ranks 133rd and Sudan ranks 131st of 194 countries.
Sudan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Myanmar | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 28.4% | 59.4% | 31.0% | Sudan |
| 2020s | 64.8% | 70.7% | 5.8% | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Myanmar or Sudan?
- Sudan, at 74.0% against 71.0% in Myanmar as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Myanmar and Sudan?
- 3.0%, with Sudan ahead.
- How many years of comparable data are there for Myanmar and Sudan?
- 18 years are reported by both, from 2008 to 2025.
- How do Myanmar and Sudan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Myanmar ranks 133rd and Sudan ranks 131st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.